Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
iTeos Therapeutics, Inc. Income Statement Banner

iTeos Therapeutics, Inc. Income Statement

ITOS Stock Analysis

Page title

Section title

Breakdown
2018
2019
2020
2021
2022
2023
Total Revenue
0.0000.0000.000344.775M267.630M12.595M
Cost of Revenue
505.000K611.000K535.000K615.000K813.000K898.000K
Gross Profit
-505.000k-611.000k-535.000k344.160M266.817M11.697M
Operating Expense
17.817M23.269M39.307M89.693M138.043M157.482M
Operating Income
-21.501m-28.048m-45.240m244.901M126.324M-151.101m
Other Income Expense
-163.000k-4.779m-5.933m-10.181m-3.263m4.083M
Total Other Income Expense
-163.000k5.713M7.150M11.563M22.412M4.083M
Pretax Income
-18.046m-22.335m-38.090m256.464M148.736M-109.030m
Tax Provision
11.000K119.000K-57.000k41.943M52.084M3.612M
Net Income
-18.057m-22.454m-38.033m214.521M96.652M-112.642m
Basic EPS
-2.400-0.640-1.0906.1002.720-3.150
Diluted EPS
-2.400-0.640-1.0905.6802.560-3.150
Basic Average Shares
7.511M35.023M35.045M35.181M35.552M35.764M
Diluted Average Shares
7.511M35.023M35.045M37.775M37.767M35.764M
Total Expenses
17.817M23.269M39.307M89.693M138.043M157.482M
Interest Income
0.0000.0000.00078.000K11.361M31.774M
Interest Expense
66.000K0.0000.0000.000-19.149m0.000
EBITDA
-17.475m-21.724m-38.772m255.685M130.390M-143.989m
Depreciation & Amortization
505.000K611.000K535.000K615.000K813.000K898.000K